Cover Image
市場調查報告書

醫藥品市場ICT投資趨勢:企業的ICT支出模式預測

ICT investment trends in pharmaceuticals

出版商 Kable 商品編碼 314911
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
醫藥品市場ICT投資趨勢:企業的ICT支出模式預測 ICT investment trends in pharmaceuticals
出版日期: 2016年11月30日 內容資訊: 英文 37 Pages
簡介

本報告依據113家製藥企業的資訊通訊技術(ICT)的投資趨勢相關調查結果為基礎,提供在企業的ICT支出核心領域(硬體設備、軟體、IT服務、通訊、諮詢)如何分配ICT預算、現狀相關驗證等,有系統的資訊。

第1章 ICT預算趨勢

  • 簡介
  • 調查人口統計
  • ICT預算的變化
  • ICT預算的分配:各核心技術領域
    • 硬體設備預算的明細
    • 軟體預算的明細
    • 第三方IT服務支出
    • 通訊預算
  • ICT預算的分配:各功能
  • IT功能的外包

第2章 ICT投資的優先順序和供應商的顧客購買傾向率

  • 簡介
    • 商業智慧(BI)
    • 內容管理
    • 雲端運算

第3章 ICT採購趨勢

  • 簡介
  • 影響IT投資策略的業務目標
  • 影響IT投資策略的IT目標
  • ICT供應商的選擇

第4章 各部門趨勢

  • 簡介
  • 固有的事業領域的IT支出計劃
  • 最大的投資事業領域
  • 商務課題

第5章 摘要

  • 為了維持市場上的競爭力,日益重視IT

第6章 附錄

  • 定義
  • 相關調查
  • 聯絡處

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KG0233CI

Summary

Factors such as emerging markets, drug accessibility, and new product launches are driving the growth of the pharmaceutical industry

However, enterprises look for technological innovation as a means of tightening overall expenditure and are looking to increase their ICT investment to aid "beyond the pill" pharmaceutical services such as apps and wearables

Key Findings

Pharmaceuticals has been one of the fastest-growing industries; however, in the last few years the sector has been witnessing constant growth, owing to factors such as the slow adoption of some new products and lower pricing flexibility.

Kable's survey shows that overall ICT expenditure in the pharmaceutical sector is set to increase in 2016 compared to 2015, with a current focus on the core ICT categories of hardware, software, and IT services.

Pharmaceutical companies are continuously looking to improve scalability and reduce cost of ownership. Consequently, they are investing in cloud computing solutions, with the majority of the cloud budget allocated towards software as a service (SaaS) and private cloud.

Synopsis

This report presents the findings from a survey of 70 pharmaceutical companies regarding their Information and Communications Technology (ICT) investment trends. The survey investigates how companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting. The report illustrates the core technologies that pharmaceutical companies are investing in, including enterprise application, network services, IoT, and cloud computing. The survey also highlights the approach to purchasing technology adopted by pharmaceutical companies. Through Kable's survey, the report aims to provide a better insight to ICT vendors and service providers when pitching their solutions to pharmaceutical companies. The report focuses on ' ICT expenditure trends for specific business areas and technologies, identifying the top three IT projects, and understanding the business challenges faced by organizations.

In particular, it provides an in-depth analysis of the following:

How ICT budgets are set to change in 2016 in terms of their overall size

Allocation across the core elements of IT spend, including hardware, software, services, communications, and consulting

Distribution of ICT money in areas such as the networks, applications, service desk, and data centers

Which ICT functions pharmaceutical companies are interested in outsourcing

pharmaceutical companies' investment priorities based on their budget allocations across core technology categories such as IoT, cloud computing, business intelligence, and security products

Factors that are influencing pharmaceutical companies' investments in each technology category

How pharmaceutical companies' IT budgets are currently allocated across various segments within a technology category

pharmaceutical companies' distribution of their ICT budget across various segments within a technology category

Vendor satisfaction ratings for various core and advanced technology categories

Insight into pharmaceutical companies' preferred buying approaches

Business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies

Factors that are influencing pharmaceutical companies' decisions to select an ICT provider

Reasons To Buy

Understand how the pharmaceutical companies ICT landscape is set to change in 2016 to prioritize your target market

Comprehend how ICT money are being allocated by pharmaceutical companies in specific geographies and size bands to improve your market penetration

Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting)

Realign your sales initiatives by understanding the current strategic objectives of pharmaceutical companies

Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (enterprise application, network services, IoT, and cloud computing)

Prioritize your focus areas by understanding which factors are influencing pharmaceutical companies ' decisions when selecting an ICT provider

Understand the changes in customers' priorities and identify the business and IT objectives that pharmaceutical companies are looking to achieve through their ICT investment strategies

Table of Contents

1 Trends in ICT budgets

  • 1.1 Introduction
  • 1.2 Survey demographics
  • 1.3 ICT budget changes
  • 1.4 ICT budget allocation by core technology area
    • 1.4.1 Hardware budget breakdown
    • 1.4.2 Software budget breakdown
    • 1.4.3 Third party IT services expenditure
    • 1.4.4 Communications expenditure
    • 1.4.5 Cloud computing budget
  • 1.5 ICT budget allocation by function
  • 1.6 Outsourced IT functions

2 ICT investment priorities and vendor satisfaction

  • 2.1 Introduction
    • 2.1.1 Enterprise applications
    • 2.1.2 Network services
    • 2.1.3 IoT
    • 2.1.4 Cloud computing

3 ICT procurement trends

  • 3.1 Introduction
  • 3.2 Business objectives influencing IT investment strategy
  • 3.3 ICT provider selection
  • 3.4 Key decision maker for purchasing technology

4 Sector-specific trends

  • 4.1 Introduction
  • 4.2 IT expenditure plans for specific systems
  • 4.3 Technology areas receiving the largest investments
  • 4.4 Business challenges

5 Summary

  • 5.1 Government restrictions and strict price controls are fueling the adoption of disruptive technologies among pharmaceutical companies

6 Appendix

  • 6.1 Definitions
  • 6.2 Further reading
  • 6.3 Contact the authors

List of Figures

  • Figure 1: Pharmaceutical companies - ICT survey geographic breakdown
  • Figure 2: Pharmaceutical companies - ICT survey breakdown by size band (number of employees)
  • Figure 3: Recent and expected ICT budget changes among pharmaceutical companies
  • Figure 4: Pharmaceutical companies' (external) ICT budget allocation, 2015 and 2016
  • Figure 5: Pharmaceutical companies' average hardware budget allocation
  • Figure 6: Average allocation of software budgets in pharmaceutical companies
  • Figure 7: Pharmaceutical companies' average IT services budget allocation
  • Figure 8: Pharmaceutical companies' average communications expenditure
  • Figure 9: Pharmaceutical companies' average cloud computing budget allocation by technology
  • Figure 10: Pharmaceutical companies' average cloud computing budget allocation by implementation type
  • Figure 11: Pharmaceutical companies' ICT budget allocation by function, 2015 and 2016
  • Figure 12: Outsourced IT functions - Pharmaceutical companies' current and future outsourcing priorities
  • Figure 13: Enterprise applications - Pharmaceutical companies' current and future investment priorities
  • Figure 14: Enterprise applications - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 15: Network services - Pharmaceutical companies' current and future investment priorities
  • Figure 16: Network services - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 17: IoT - Pharmaceutical companies' current and future investment priorities
  • Figure 18: IoT - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 19: Cloud computing - Pharmaceutical companies' current and future investment priorities
  • Figure 20: Cloud computing - selected primary provider and vendor satisfaction among pharmaceutical companies
  • Figure 21: Business objectives which influence pharmaceutical companies' IT investment strategy
  • Figure 22: Factors influencing pharmaceutical companies' decision to choose an ICT provider
  • Figure 23: Role of key entities in making ICT purchasing decisions
  • Figure 24: IT expenditure plans in 2016 compared to 2015, for specific technology categories within pharmaceutical companies
  • Figure 25: Top three IT projects in 2016 for pharmaceutical companies
  • Figure 26: Importance of the following business challenges for pharmaceutical companies
Back to Top